187,565 Shares in Carmell Co. (NASDAQ:CTCX) Bought by Citadel Advisors LLC

Citadel Advisors LLC bought a new position in shares of Carmell Co. (NASDAQ:CTCX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 187,565 shares of the company's stock, valued at approximately $54,000. Citadel Advisors LLC owned approximately 0.90% of Carmell as of its most recent SEC filing.

Separately, Antara Capital LP bought a new stake in Carmell during the fourth quarter worth about $28,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Carmell Trading Down 1.1%

CTCX traded down $0.03 during midday trading on Thursday, reaching $2.65. 30,792 shares of the company's stock traded hands, compared to its average volume of 3,941,864. Carmell Co. has a 52 week low of $0.17 and a 52 week high of $2.33. The firm has a fifty day moving average of $1.29 and a two-hundred day moving average of $0.64.

Carmell Company Profile

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.